Form 4: Lipocine Director Buys Shares
Insider Transaction (Form 4)
John W. Higuchi, a Director of Lipocine Inc., purchased 12,561 shares of common stock on September 28, 2026 for $2.16 per share.
Summary
- Open-market purchase: acquired 12,561 Common stock at $2.16 ($27,132) on September 28, 2026; holds 216,358 after (Direct).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $27,132, committing personal capital to the stock.
Insider Transactions
John W. Higuchi — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-28 | Open-market purchase | Common stock | 12,561 | $2 | $27.1K | 216,358 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-28 | Open-market purchase (12,561 shares) |
Keywords
insider transaction, Form 4, LPCN, Lipocine Inc., bullish, John W. Higuchi
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.